Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice
- PMID: 22430833
- DOI: 10.1093/infdis/jis177
Probiotics are effective for the prevention and treatment of Citrobacter rodentium-induced colitis in mice
Abstract
Background: Probiotics prevent disease induced by Citrobacter rodentium, a murine-specific enteric pathogen. Whether probiotics can be used to interrupt the infectious process following initiation of infection was determined.
Methods: C57BL/6 adult and neonatal mice were challenged with C. rodentium, and a probiotic mixture containing Lactobacillus helveticus and Lactobacillus rhamnosus was provided 1 week before bacterial challenge, concurrently with infection, or 3 days and 6 days after infection. Mice were sacrificed 10 days after infection, and disease severity was assessed by histological analysis and in vivo intestinal permeability assay. Inflammatory pathways and the composition of the fecal microbiome were assessed in adult mice.
Results: Preadministration and coadministration of probiotics ameliorated C. rodentium-induced barrier dysfunction, epithelial hyperplasia, and binding of the pathogen to host colonocytes in adults, with similar findings in neonatal mice. Upregulated tumor necrosis factor α and interferon γ transcripts were suppressed in the pretreated probiotic group, whereas interleukin 17 transcription was suppressed with probiotics given up to 3 days after infection. Probiotics promoted transcription of interleukin 10 and FOXP3, and increased follicular T-regulatory cells in pretreatment mice. C. rodentium infection resulted in an altered fecal microbiome, which was normalized with probiotic intervention.
Conclusions: This study provides evidence that probiotics can prevent illness and treat disease in an animal model of infectious colitis.
Similar articles
-
Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors.Am J Physiol Gastrointest Liver Physiol. 2008 Jan;294(1):G295-306. doi: 10.1152/ajpgi.00173.2007. Epub 2007 Nov 21. Am J Physiol Gastrointest Liver Physiol. 2008. PMID: 18032474
-
Preinoculation with the probiotic Lactobacillus acidophilus early in life effectively inhibits murine Citrobacter rodentium colitis.Pediatr Res. 2005 Dec;58(6):1185-91. doi: 10.1203/01.pdr.0000183660.39116.83. Pediatr Res. 2005. PMID: 16306191
-
The Probiotic Lactobacillus Prevents Citrobacter rodentium-Induced Murine Colitis in a TLR2-Dependent Manner.J Microbiol Biotechnol. 2016 Jul 28;26(7):1333-40. doi: 10.4014/jmb.1602.02004. J Microbiol Biotechnol. 2016. PMID: 27056471
-
Probiotics prevent death caused by Citrobacter rodentium infection in neonatal mice.J Infect Dis. 2010 Jan 1;201(1):81-91. doi: 10.1086/648614. J Infect Dis. 2010. PMID: 19961304
-
A comprehensive post-market review of studies on a probiotic product containing Lactobacillus helveticus R0052 and Lactobacillus rhamnosus R0011.Benef Microbes. 2011 Dec 1;2(4):319-34. doi: 10.3920/BM2011.0032. Benef Microbes. 2011. PMID: 22146691 Review.
Cited by
-
Mouse models for bacterial enteropathogen infections: insights into the role of colonization resistance.Gut Microbes. 2023 Jan-Dec;15(1):2172667. doi: 10.1080/19490976.2023.2172667. Gut Microbes. 2023. PMID: 36794831 Free PMC article.
-
Animal models to study acute and chronic intestinal inflammation in mammals.Gut Pathog. 2015 Nov 10;7:29. doi: 10.1186/s13099-015-0076-y. eCollection 2015. Gut Pathog. 2015. PMID: 26561503 Free PMC article. Review.
-
Pre-treatment with Bifidobacterium breve UCC2003 modulates Citrobacter rodentium-induced colonic inflammation and organ specificity.Microbiology (Reading). 2012 Nov;158(Pt 11):2826-2834. doi: 10.1099/mic.0.060830-0. Epub 2012 Aug 17. Microbiology (Reading). 2012. PMID: 22902730 Free PMC article.
-
Leaky Gut and the Ingredients That Help Treat It: A Review.Molecules. 2023 Jan 7;28(2):619. doi: 10.3390/molecules28020619. Molecules. 2023. PMID: 36677677 Free PMC article. Review.
-
The investigation of P1 gene in Mycoplasma pneumonia isolated from atypic pneumonia by molecular methods, determine IgG antibody and MIC to ciprofloxacin antibiotic.New Microbes New Infect. 2022 Jan 10;46:100954. doi: 10.1016/j.nmni.2022.100954. eCollection 2022 Mar. New Microbes New Infect. 2022. PMID: 35251667 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources